Peak Bio (PKBO) News Today → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free PKBO Stock Alerts $0.0086 0.00 (0.00%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 1, 2024 | globenewswire.comAkari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger EntityApril 11, 2024 | msn.comOppenheimer starts Q32 Bio at outperform, cites lead assetMarch 6, 2024 | msn.comAkari Therapeutics enters merger deal with Peak BioMarch 5, 2024 | prnewswire.comShareholder Alert: Ademi LLP investigates whether Peak Bio Inc. has obtained a Fair Price in its transaction with AkariMarch 5, 2024 | globenewswire.comAkari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) ToolkitFebruary 17, 2024 | benzinga.comPyramid Peak Foundation's Net WorthFebruary 7, 2024 | markets.businessinsider.comPeak Bio Raises Capital via Convertible Promissory NotesJanuary 4, 2024 | finance.yahoo.comPeak Bio, Inc. Awarded Patent with Broad Coverage for Thailanstatin-ADC platform technology (PH-1) a Payload with Novel Immunomodulatory Effects that Target RNA SplicingDecember 12, 2023 | businessinsider.comWhen to watch the spectacular Geminid meteor shower this week. NASA says skies are ideal for viewing it.September 19, 2023 | finance.yahoo.comPeak Bio, Inc. Announces Filing of Provisional Patent Applications for PH-1, a Novel and Specific Immunomodulatory ADC payload platform targeting RNA splicingSeptember 14, 2023 | finance.yahoo.comInsider Buying: Hoyoung Huh Acquires 47,000 Shares of Peak Bio Inc (PKBO)August 31, 2023 | theglobeandmail.comBioPharma Uplists to OTCQBAugust 31, 2023 | benzinga.comPeak Bio, Inc. Announces Up-listing to OTCQB MarketAugust 31, 2023 | finance.yahoo.comPeak Bio, Inc., Announces Appointment of Michael Friedman to Board of DirectorsAugust 31, 2023 | finance.yahoo.comPeak Bio, Inc., Announces Appointment of Michael Friedman to Board of DirectorsAugust 31, 2023 | finance.yahoo.comPeak Bio, Inc. Announces Up-listing to OTCQB MarketAugust 24, 2023 | finance.yahoo.comPeak Bio, Inc. Announces Amendment and Continued Access to Equity Line of up to $100 Million USD via an Accelerated Common Stock Purchase Transaction with White Lion CapitalAugust 23, 2023 | finance.yahoo.comPeak Bio, Inc. Presents Preclinical Data Highlighting Potential of Differentiated Trop2 PH1 (Novel Payload) ADC in Poster at 2023 AACR Annual MeetingAugust 10, 2023 | msn.comBio-Rad: A Cash Flow Returns On Investments AnalysisFebruary 25, 2023 | msn.com"I don't need a therapist because I have Talat Mahmood": A sneak peak into the legendary singer's biographyFebruary 20, 2023 | yahoo.comBioAro Unveils Its Targeted Cardiac Panel for Patients Facing the Risk of Heart Failure During the Peak of Heart MonthJanuary 28, 2023 | nypost.comFinding peak travel outfits with Alan CummingJanuary 9, 2023 | msn.comWhy Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day SessionDecember 29, 2022 | marketbeat.comTrading was temporarily halted for "PKBO" at 10:12 AM with a stated reason of "LULD pause."November 25, 2022 | seekingalpha.comNewly public Peak Bio stock rallies 27% in wake of SPAC mergerNovember 25, 2022 | benzinga.comWhy Canoo Shares Are Trading Higher By Over 12%? Here Are 32 Stocks Moving In Friday's Mid-Day SessionNovember 25, 2022 | marketbeat.comTrading was temporarily halted for "PKBO" at 10:11 AM with a stated reason of "LULD pause."November 25, 2022 | marketbeat.comTrading was temporarily halted for "PKBO" at 09:11 AM with a stated reason of "LULD pause."November 25, 2022 | marketbeat.comTrading was temporarily halted for "PKBO" at 09:11 AM with a stated reason of "LULD pause."November 4, 2022 | seekingalpha.comNewly public Peak Bio falls for second day following SPAC mergerNovember 4, 2022 | investorplace.comWhat Is Going on With Peak Bio (PKBO) Stock Today?November 4, 2022 | marketbeat.comTrading was temporarily halted for "PKBO" at 01:11 PM with a stated reason of "LULD pause."November 4, 2022 | marketbeat.comTrading was temporarily halted for "PKBO" at 10:11 AM with a stated reason of "LULD pause."November 4, 2022 | marketbeat.comTrading was temporarily halted for "PKBO" at 10:11 AM with a stated reason of "LULD pause."November 4, 2022 | marketbeat.comTrading was temporarily halted for "PKBO" at 10:11 AM with a stated reason of "LULD pause."November 4, 2022 | marketbeat.comTrading was temporarily halted for "PKBO" at 09:11 AM with a stated reason of "LULD pause."November 3, 2022 | marketbeat.comTrading was temporarily halted for "PKBO" at 03:11 PM with a stated reason of "LULD pause."November 2, 2022 | marketbeat.comTrading was temporarily halted for "PKBO" at 03:11 PM with a stated reason of "LULD pause."November 2, 2022 | marketbeat.comTrading was temporarily halted for "PKBO" at 09:11 AM with a stated reason of "LULD pause." Get Peak Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PKBO and its competitors with MarketBeat's FREE daily newsletter. Email Address The World’s Richest Man Blindsided by AI (Ad)These billionaires know that early investors in AI stand to make a lot of money. The same is true for everyday Americans... including you. Get the full story here. PKBO Media Mentions By Week PKBO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PKBO News Sentiment▼0.000.57▲Average Medical News Sentiment PKBO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PKBO Articles This Week▼00▲PKBO Articles Average Week Get Peak Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PKBO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SQZ News Today AMPE News Today ATHX News Today CALA News Today SMFL News Today MOTS News Today NVTA News Today ADTX News Today APVO News Today BTTX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PKBO) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Peak Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
